News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
510,433 Results
Type
Article (9192)
Company Profile (147)
Press Release (501001)
Multimedia
Podcasts (4)
Webinars (6)
Section
Business (172132)
Career Advice (327)
Deals (26523)
Drug Delivery (13)
Drug Development (55407)
Employer Resources (17)
FDA (10367)
Job Trends (8939)
News (247215)
Policy (18815)
Tag
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (3)
2027 Biotech Bay Standard (8)
2027 Biotech Beach Elite (1)
2027 Biotech Beach Standard (1)
2027 Genetown Elite (2)
2027 Genetown Standard (3)
2027 Pharm Country Digital (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (4)
Academia (583)
Accelerated approval (28)
ADA (18)
Adcomms (1)
Allergies (113)
Alliances (34818)
ALS (121)
Alzheimer's disease (1041)
Antibody-drug conjugate (ADC) (307)
Approvals (11076)
Artificial intelligence (377)
ASCO (173)
Autoimmune disease (234)
Automation (32)
Bankruptcy (265)
Belgium (4)
Best Places to Work (7273)
BIO (40)
Biologics (14)
BIOSECURE Act (1)
Biosimilars (128)
BioSpace Insights (19)
Biotechnology (95)
Bispecific (3)
Bladder cancer (152)
Brain cancer (36)
Breast cancer (550)
Cancer (4041)
Cardiovascular disease (241)
Career advice (266)
Career pathing (2)
CAR-T (188)
CDC (2)
CDMO (24)
Celiac Disease (1)
Cell therapy (518)
Cervical cancer (36)
Clinical research (50442)
Collaboration (1400)
Commercialization (7)
Compensation (1553)
Complete response letters (35)
COVID-19 (844)
CRISPR (68)
C-suite (854)
Cystic fibrosis (87)
Data (6328)
Denatured (4)
Depression (108)
Dermatology (83)
Diabetes (389)
Diagnostics (4567)
Digital health (41)
Diversity (2)
Diversity, equity & inclusion (7)
Drug discovery (173)
Drug pricing (18)
Drug shortages (2)
Duchenne muscular dystrophy (199)
Earnings (75077)
Editorial (1)
Employer branding (2)
Employer resources (17)
Events (91698)
Executive appointments (743)
FDA (13329)
Fibrodysplasia Ossificans Progressiva (10)
Friedreich's ataxia (19)
Frontotemporal dementia (28)
Funding (1019)
Gene editing (130)
Generative AI (14)
Gene therapy (361)
GLP-1 (368)
Government (1076)
Grass and pollen (2)
Guidances (293)
Healthcare (9995)
Hematology (100)
HIV (58)
Huntington's disease (23)
Idiopathic pulmonary fibrosis (1)
IgA nephropathy (72)
Immunology and inflammation (116)
Immuno-oncology (63)
Indications (176)
Infectious disease (1053)
Inflammatory bowel disease (141)
Inflation Reduction Act (5)
Influenza (93)
Intellectual property (278)
Interviews (43)
IPO (12740)
IRA (2)
Job creations (2035)
Job search strategy (253)
JPM (2)
Kidney cancer (17)
Kidney disease (50)
Layoffs (61)
Leadership (1)
Legal (5305)
Licensing (26)
Liver cancer (49)
Longevity (22)
Lung cancer (581)
Lung diease (8)
Lymphoma (288)
Machine learning (32)
Management (3)
Manufacturing (637)
Marketing (9)
MASH (125)
Medical affairs (2)
Medical device (9293)
Medtech (9460)
Mergers & acquisitions (14886)
Metabolic disorders (807)
mRNA (73)
Multiple sclerosis (110)
NASH (4)
Neurodegenerative disease (248)
Neuropsychiatric disorders (41)
Neuroscience (2006)
NextGen: Class of 2026 (3323)
Non-profit (981)
Obesity (266)
Opinion (16)
Ovarian cancer (169)
Pain (191)
Pancreatic cancer (225)
Parkinson's disease (232)
Partnered (13)
Patents (531)
Patient advocacy (1)
Patient recruitment (561)
Patient selection (14)
Peanut (39)
People (42929)
Peptides (5)
Pharmaceutical (31)
Pharmacy benefit managers (10)
Phase 1 (16196)
Phase 2 (22560)
Phase 3 (15255)
Pipeline (8345)
Policy (24)
Postmarket research (1634)
Preclinical (6824)
Press Release (49)
Prostate cancer (208)
Psychedelics (10)
Radiopharmaceuticals (209)
Rare diseases (625)
Real estate (3275)
Recruiting (6)
Regenerative medicine (7)
Regulatory (15929)
Reports (26)
Research institute (673)
Resumes & cover letters (50)
Rett syndrome (45)
RNA editing (8)
RSV (49)
Schizophrenia (120)
Series A (176)
Series B (137)
Service/supplier (5)
Sickle cell disease (64)
Spinal muscular atrophy (94)
Sponsored (8)
Startups (2106)
Stomach cancer (3)
Substance use disorders (16)
Supply chain (55)
Vaccines (358)
Venture capital (17)
Weight loss (100)
Wet AMD (1)
Women's health (92)
Date
Today (3)
Last 7 days (354)
Last 30 days (1473)
Last 365 days (19875)
2026 (14841)
2025 (20196)
2024 (24033)
2023 (27620)
2022 (36111)
2021 (39317)
2020 (35486)
2019 (25202)
2018 (18917)
2017 (20210)
2016 (19273)
2015 (25666)
2014 (22664)
2013 (19069)
2012 (21106)
2011 (21347)
2010 (21077)
Location
Africa (264)
Alabama (80)
Alaska (3)
Arizona (314)
Arkansas (12)
Asia (20353)
Australia (3317)
California (12660)
Canada (3348)
China (620)
Colorado (518)
Connecticut (446)
Delaware (231)
Europe (33915)
Florida (1903)
Georgia (415)
Hawaii (3)
Idaho (47)
Illinois (784)
India (70)
Indiana (412)
Iowa (21)
Japan (464)
Kansas (107)
Kentucky (34)
Louisiana (27)
Maine (28)
Maryland (1267)
Massachusetts (8429)
Michigan (319)
Minnesota (614)
Mississippi (4)
Missouri (86)
Montana (25)
Nebraska (11)
Nevada (126)
New Hampshire (60)
New Jersey (2889)
New Mexico (20)
New York (2973)
North Carolina (1347)
North Dakota (4)
Northern California (6396)
Ohio (304)
Oklahoma (15)
Oregon (16)
Pennsylvania (2361)
Puerto Rico (26)
Rhode Island (30)
South America (436)
South Carolina (78)
South Dakota (1)
Southern California (5263)
Tennessee (132)
Texas (2079)
United States (41536)
Utah (380)
Vermont (1)
Virginia (169)
Washington D.C. (40)
Washington State (984)
West Virginia (1)
Wisconsin (98)
Wyoming (3)
510,433 Results for "octapharma usa inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Octapharma USA Announces Expanded FDA Approval of wilate® for von Willebrand Disease Prophylaxis in Children Younger Than 6 Years
July 8, 2026
·
5 min read
Press Releases
Octapharma to build $1.5 billion state-of-the-art critical care manufacturing facility in Rock Hill, SC
July 29, 2026
·
3 min read
Business
Octapharma USA Appoints Biopharma Industry Veteran Kelly Hearn Vice President of Commercial Marketing & Development
Octapharma USA, Inc. has appointed pharmaceutical industry veteran Kelly Hearn as Vice President of Commercial Development & Marketing, assuming immediate leadership of the product marketing team as the company continues to grow its presence in the U.S. market.
May 20, 2024
·
2 min read
Press Releases
Abram Scientific Secures $11.75M Series A Funding Led by Octapharma AG
February 25, 2026
·
6 min read
Press Releases
Knoa Pharma to Present Pipeline Assets at LSX Congress USA 2026
September 22, 2026
·
3 min read
Press Releases
AIVITA Biomedical Nominated for 2026 Prix Galien USA Award
August 14, 2026
·
4 min read
Press Releases
Octapharma USA: JAMA Publishes Results for Investigational Four-Factor Prothrombin Complex Concentrate in Cardiac Surgical Bleeding
April 2, 2025
·
4 min read
Press Releases
Takara Bio USA, Inc. Announces the Retirement of Carol Lou, Appoints Andrew Farmer as President and CEO
July 9, 2026
·
4 min read
Press Releases
MediBeacon Transdermal GFR System Nominated for 2026 Prix Galien USA Best Medical Technology
August 18, 2026
·
3 min read
FDA
Octapharma USA: FDA Grants Orphan Drug Exclusivity to wilate®, the First VWF Concentrate for Prophylaxis in All Types of VWD
Octapharma USA , Inc. announced the U.S. Food and Drug Administration (FDA) has granted orphan drug exclusivity for wilate®, von Willebrand Factor/Coagulation Factor VIII Complex (Human) Lyophilized Powder for Solution for Intravenous Injection, for routine prophylaxis to reduce the frequency of bleeding episodes in adults and children 6 years of age and older with von Willebrand disease (VWD).
April 29, 2024
·
4 min read
1 of 51,044
Next
